1.Purdy, MA et al. (2017) ICTV virus taxonomy profile: Hepeviridae. The Journal of General Virology 98, 2645–2646.
2.Smith, DB et al. (2016) Proposed reference sequences for hepatitis E virus subtypes. The Journal of General Virology 97, 537–542.
3.Pavio, N et al. (2010) Zoonotic hepatitis E: animal reservoirs and emerging risks. Veterinary Research 41, 46.
4.Nimgaonkar, I et al. (2018) Hepatitis E virus: advances and challenges. Nature Reviews Gastroenterology & Hepatology 15, 96–110.
5.Dalton, HR et al. (2009) Persistent carriage of hepatitis E virus in patients with HIV infection. The New England Journal of Medicine 361, 1025–1027.
6.Kamar, N et al. (2008) Hepatitis E virus and chronic hepatitis in organ-transplant recipients. The New England Journal of Medicine 358, 811–817.
7.Anon (2015) Hepatitis E vaccine: WHO position paper, May 2015. Weekly Epidemiological Record 90, 185–200.
8.Khuroo, MS (2011) Discovery of hepatitis E: the epidemic non-A, non-B hepatitis 30 years down the memory lane. Virus Research 161, 3–14.
9.Khuroo, MS et al. (2016) Hepatitis E: discovery, global impact, control and cure. World Journal of Gastroenterology 22, 7030–7045.
10.Nouhin, J et al. (2015) Low frequency of acute hepatitis E virus (HEV) infections but high past HEV exposure in subjects from Cambodia with mild liver enzyme elevations, unexplained fever or immunodeficiency due to HIV-1 infection. Journal of Clinical Virology: the Official Publication of the Pan American Society for Clinical Virology 71, 22–27.
11.Nouhin, J et al. (2016) Hepatitis E virus antibody prevalence, RNA frequency, and genotype among blood donors in Cambodia (Southeast Asia). Transfusion 56, 2597–2601.
12.Yamada, H et al. (2015) Hepatitis E virus in Cambodia: prevalence among the general population and complete genome sequence of genotype 4. PLoS ONE 10, e0136903.
13.Garson, JA et al. (2012) Minor groove binder modification of widely used TaqMan probe for hepatitis E virus reduces risk of false negative real-time PCR results. Journal of Virological Methods 186, 157–160.
14.Anon. National Institute of Statistics, Directorate General for Health, and ICF International (2015) Cambodia Demographic and Health Survey 2014. Phnom Penh, Cambodia, and Rockville, Maryland, USA: National Institute of Statistics, Directorate General for Health, and ICF International, pp. 11–22.
15.Oliveira, R et al. (2017) Seroprevalence of hepatitis E virus antibodies in Portuguese children. The Pediatric Infectious Disease Journal 36, 623–626.
16.Krumbholz, A et al. (2014) Prevalence of hepatitis E virus antibodies in children in Germany. The Pediatric Infectious Disease Journal 33, 258–262.
17.Chhour, YM et al. (2002) Hospital-based diagnosis of hemorrhagic fever, encephalitis, and hepatitis in Cambodian children. Emerging Infectious Diseases 8, 485–489.
18.Buchy, P et al. (2004) [Prevalence of hepatitis A, B, C and E virus markers among patients with elevated levels of Alanine aminotransferase and Aspartate aminotransferase in Phnom Penh (Cambodia) and Nha Trang (Central Vietnam)]. Bulletin De La Societe De Pathologie Exotique 97, 165–171.
19.Wenzel, JJ et al. (2014) Decline in hepatitis E virus antibody prevalence in southeastern Germany, 1996–2011. Hepatology 60, 1180–1186.
20.Christensen, PB et al. (2008) Time trend of the prevalence of hepatitis E antibodies among farmers and blood donors: a potential zoonosis in Denmark. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 47, 1026–1031.
22.Gallian, P et al. (2014) Hepatitis E virus infections in blood donors, France. Emerging Infectious Diseases 20, 1914–1917.
23.Koot, H et al. (2015) Frequent hepatitis E in the Netherlands without traveling or immunosuppression. Journal of Clinical Virology: the Official Publication Of the Pan American Society for Clinical Virology 62, 38–40.